These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 29196128)

  • 1. Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.
    Long J; Jiang C; Liu B; Dai Q; Hua R; Chen C; Zhang B; Li H
    Cancer Lett; 2018 Jun; 423():113-126. PubMed ID: 29196128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.
    Jiang C; Long J; Liu B; Xu M; Wang W; Xie X; Wang X; Kuang M
    J Exp Clin Cancer Res; 2017 Jul; 36(1):99. PubMed ID: 28750679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
    Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
    Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
    Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
    Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
    Shu G; Su H; Wang Z; Lai S; Wang Y; Liu X; Dai L; Bi Y; Chen W; Huang W; Zhou Z; He S; Dai H; Tang B
    J Exp Clin Cancer Res; 2021 Jan; 40(1):45. PubMed ID: 33499874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-515-5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway.
    Ni JS; Zheng H; Ou YL; Tao YP; Wang ZG; Song LH; Yan HL; Zhou WP
    Surg Oncol; 2020 Sep; 34():113-120. PubMed ID: 32891315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features.
    Gu Y; Wei X; Sun Y; Gao H; Zheng X; Wong LL; Jin L; Liu N; Hernandez B; Peplowska K; Zhao X; Zhan QM; Feng XH; Tang ZY; Ji J
    Cancer Res; 2019 Mar; 79(5):941-953. PubMed ID: 30530815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-490-5p inhibits the stemness of hepatocellular carcinoma cells by targeting ECT2.
    Yu Y; Cai O; Wu P; Tan S
    J Cell Biochem; 2019 Jan; 120(1):967-976. PubMed ID: 30206962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma.
    Gu Y; Ji F; Liu N; Zhao Y; Wei X; Hu S; Jia W; Wang XW; Budhu A; Ji J; Zhao B; Roessler S; Zheng X; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):268. PubMed ID: 33256802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3.
    Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W
    Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
    Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma.
    Xu X; Tao Y; Niu Y; Wang Z; Zhang C; Yu Y; Ma L
    Aging (Albany NY); 2019 Sep; 11(18):7639-7662. PubMed ID: 31527306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of LINC01013/miR-6795-5p/FMNL3 axis in the regulation of hepatocellular carcinoma stem cell features.
    Wang W; Xu S; Di Y; Zhang Z; Li Q; Guo K; Lv Y; Wang B
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):652-662. PubMed ID: 33847733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression.
    Chen M; Wu L; Tu J; Zhao Z; Fan X; Mao J; Weng Q; Wu X; Huang L; Xu M; Ji J
    EBioMedicine; 2018 Sep; 35():142-154. PubMed ID: 30111512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
    Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
    Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.